Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum

Ho Chul Shin, Christopher P. Landowski, Duxin Sun, Balvinder S. Vig, Insook Kim, Sachin Mittal, Majella Lane, Gustavo Rosania, John C. Drach, Gordon L. Amidon

Research output: Contribution to journalArticleScientificpeer-review

18 Citations (Scopus)

Abstract

We have cloned and functionally expressed a sodium-dependent human nucleoside transporter, hCNT2, from a CNS cancer cell line U251. Our cDNA clone of hCNT2 had the same predicted amino acid sequence as the previously cloned hCNT2 transporter. Of the several cell lines studied, the best hCNT2 transport function was obtained when transiently expressed in U251 cells. Na + -dependent uptake of [ 3 H]inosine in U251 cells transiently expressing hCNT2 was 50-fold greater than that in non-transfected cells, and uptake in Na + -containing medium was approximately 30-fold higher than that at Na + -free condition. The hCNT2 displayed saturable uptake of [ 3 H]inosine with K m of 12.8μM and V max of 6.66pmol/mg protein/5min. Uptake of [ 3 H]inosine was significantly inhibited by the purine nucleoside drugs dideoxyinosine and cladribine, but not by acyclic nucleosides including acyclovir, ganciclovir, and their prodrugs valacyclovir and valganciclovir. This indicates that the closed ribose ring is important for binding of nucleoside drugs to hCNT2. Among several pyrimidine nucleosides, hCNT2 favorably interacted with the uridine analogue floxuridine. Interestingly, we found that benzimidazole analogues, including maribavir, 5,6-dichloro-2-bromo-1-β-D-ribofuranosylbenzimidazole (BDCRB), and 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), were strong inhibitors of inosine transport, even though they have a significantly different heterocycle structure compared to a typical purine ring. As measured by GeneChip arrays, mRNA expression of hCNT2 in human duodenum was 15-fold greater than that of hCNT1 or hENT2. Further, the rCNT2 expression in rat duodenum was 20-fold higher than rCNT1, rENT1 or rENT2. This suggests that hCNT2 (and rCNT2) may have a significant role in uptake of nucleoside drugs from the intestine and is a potential transporter target for the development of nucleoside and nucleoside-mimetic drugs.

Original languageEnglish
Pages (from-to)696-703
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume307
Issue number3
DOIs
Publication statusPublished - 1 Aug 2003
MoE publication typeA1 Journal article-refereed

Fingerprint

Nucleoside Transport Proteins
Inosine
Duodenum
Nucleosides
Sodium
valacyclovir
Pharmaceutical Preparations
Cells
Floxuridine
Pyrimidine Nucleosides
Cladribine
Purine Nucleosides
Didanosine
Cell Line
Ganciclovir
Ribose
Acyclovir
Uridine
Prodrugs
Intestines

Keywords

  • BDCRB
  • Cloning
  • Floxuridine
  • Functional expression
  • GeneChip expression
  • hCNT2
  • Maribavir
  • U251

Cite this

Shin, Ho Chul ; Landowski, Christopher P. ; Sun, Duxin ; Vig, Balvinder S. ; Kim, Insook ; Mittal, Sachin ; Lane, Majella ; Rosania, Gustavo ; Drach, John C. ; Amidon, Gordon L. / Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. In: Biochemical and Biophysical Research Communications. 2003 ; Vol. 307, No. 3. pp. 696-703.
@article{e59ad54035a9477fb05a7079a5b1de51,
title = "Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum",
abstract = "We have cloned and functionally expressed a sodium-dependent human nucleoside transporter, hCNT2, from a CNS cancer cell line U251. Our cDNA clone of hCNT2 had the same predicted amino acid sequence as the previously cloned hCNT2 transporter. Of the several cell lines studied, the best hCNT2 transport function was obtained when transiently expressed in U251 cells. Na + -dependent uptake of [ 3 H]inosine in U251 cells transiently expressing hCNT2 was 50-fold greater than that in non-transfected cells, and uptake in Na + -containing medium was approximately 30-fold higher than that at Na + -free condition. The hCNT2 displayed saturable uptake of [ 3 H]inosine with K m of 12.8μM and V max of 6.66pmol/mg protein/5min. Uptake of [ 3 H]inosine was significantly inhibited by the purine nucleoside drugs dideoxyinosine and cladribine, but not by acyclic nucleosides including acyclovir, ganciclovir, and their prodrugs valacyclovir and valganciclovir. This indicates that the closed ribose ring is important for binding of nucleoside drugs to hCNT2. Among several pyrimidine nucleosides, hCNT2 favorably interacted with the uridine analogue floxuridine. Interestingly, we found that benzimidazole analogues, including maribavir, 5,6-dichloro-2-bromo-1-β-D-ribofuranosylbenzimidazole (BDCRB), and 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), were strong inhibitors of inosine transport, even though they have a significantly different heterocycle structure compared to a typical purine ring. As measured by GeneChip arrays, mRNA expression of hCNT2 in human duodenum was 15-fold greater than that of hCNT1 or hENT2. Further, the rCNT2 expression in rat duodenum was 20-fold higher than rCNT1, rENT1 or rENT2. This suggests that hCNT2 (and rCNT2) may have a significant role in uptake of nucleoside drugs from the intestine and is a potential transporter target for the development of nucleoside and nucleoside-mimetic drugs.",
keywords = "BDCRB, Cloning, Floxuridine, Functional expression, GeneChip expression, hCNT2, Maribavir, U251",
author = "Shin, {Ho Chul} and Landowski, {Christopher P.} and Duxin Sun and Vig, {Balvinder S.} and Insook Kim and Sachin Mittal and Majella Lane and Gustavo Rosania and Drach, {John C.} and Amidon, {Gordon L.}",
year = "2003",
month = "8",
day = "1",
doi = "10.1016/S0006-291X(03)01259-2",
language = "English",
volume = "307",
pages = "696--703",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press",
number = "3",

}

Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. / Shin, Ho Chul; Landowski, Christopher P.; Sun, Duxin; Vig, Balvinder S.; Kim, Insook; Mittal, Sachin; Lane, Majella; Rosania, Gustavo; Drach, John C.; Amidon, Gordon L.

In: Biochemical and Biophysical Research Communications, Vol. 307, No. 3, 01.08.2003, p. 696-703.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum

AU - Shin, Ho Chul

AU - Landowski, Christopher P.

AU - Sun, Duxin

AU - Vig, Balvinder S.

AU - Kim, Insook

AU - Mittal, Sachin

AU - Lane, Majella

AU - Rosania, Gustavo

AU - Drach, John C.

AU - Amidon, Gordon L.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - We have cloned and functionally expressed a sodium-dependent human nucleoside transporter, hCNT2, from a CNS cancer cell line U251. Our cDNA clone of hCNT2 had the same predicted amino acid sequence as the previously cloned hCNT2 transporter. Of the several cell lines studied, the best hCNT2 transport function was obtained when transiently expressed in U251 cells. Na + -dependent uptake of [ 3 H]inosine in U251 cells transiently expressing hCNT2 was 50-fold greater than that in non-transfected cells, and uptake in Na + -containing medium was approximately 30-fold higher than that at Na + -free condition. The hCNT2 displayed saturable uptake of [ 3 H]inosine with K m of 12.8μM and V max of 6.66pmol/mg protein/5min. Uptake of [ 3 H]inosine was significantly inhibited by the purine nucleoside drugs dideoxyinosine and cladribine, but not by acyclic nucleosides including acyclovir, ganciclovir, and their prodrugs valacyclovir and valganciclovir. This indicates that the closed ribose ring is important for binding of nucleoside drugs to hCNT2. Among several pyrimidine nucleosides, hCNT2 favorably interacted with the uridine analogue floxuridine. Interestingly, we found that benzimidazole analogues, including maribavir, 5,6-dichloro-2-bromo-1-β-D-ribofuranosylbenzimidazole (BDCRB), and 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), were strong inhibitors of inosine transport, even though they have a significantly different heterocycle structure compared to a typical purine ring. As measured by GeneChip arrays, mRNA expression of hCNT2 in human duodenum was 15-fold greater than that of hCNT1 or hENT2. Further, the rCNT2 expression in rat duodenum was 20-fold higher than rCNT1, rENT1 or rENT2. This suggests that hCNT2 (and rCNT2) may have a significant role in uptake of nucleoside drugs from the intestine and is a potential transporter target for the development of nucleoside and nucleoside-mimetic drugs.

AB - We have cloned and functionally expressed a sodium-dependent human nucleoside transporter, hCNT2, from a CNS cancer cell line U251. Our cDNA clone of hCNT2 had the same predicted amino acid sequence as the previously cloned hCNT2 transporter. Of the several cell lines studied, the best hCNT2 transport function was obtained when transiently expressed in U251 cells. Na + -dependent uptake of [ 3 H]inosine in U251 cells transiently expressing hCNT2 was 50-fold greater than that in non-transfected cells, and uptake in Na + -containing medium was approximately 30-fold higher than that at Na + -free condition. The hCNT2 displayed saturable uptake of [ 3 H]inosine with K m of 12.8μM and V max of 6.66pmol/mg protein/5min. Uptake of [ 3 H]inosine was significantly inhibited by the purine nucleoside drugs dideoxyinosine and cladribine, but not by acyclic nucleosides including acyclovir, ganciclovir, and their prodrugs valacyclovir and valganciclovir. This indicates that the closed ribose ring is important for binding of nucleoside drugs to hCNT2. Among several pyrimidine nucleosides, hCNT2 favorably interacted with the uridine analogue floxuridine. Interestingly, we found that benzimidazole analogues, including maribavir, 5,6-dichloro-2-bromo-1-β-D-ribofuranosylbenzimidazole (BDCRB), and 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), were strong inhibitors of inosine transport, even though they have a significantly different heterocycle structure compared to a typical purine ring. As measured by GeneChip arrays, mRNA expression of hCNT2 in human duodenum was 15-fold greater than that of hCNT1 or hENT2. Further, the rCNT2 expression in rat duodenum was 20-fold higher than rCNT1, rENT1 or rENT2. This suggests that hCNT2 (and rCNT2) may have a significant role in uptake of nucleoside drugs from the intestine and is a potential transporter target for the development of nucleoside and nucleoside-mimetic drugs.

KW - BDCRB

KW - Cloning

KW - Floxuridine

KW - Functional expression

KW - GeneChip expression

KW - hCNT2

KW - Maribavir

KW - U251

UR - http://www.scopus.com/inward/record.url?scp=0042671494&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(03)01259-2

DO - 10.1016/S0006-291X(03)01259-2

M3 - Article

C2 - 12893280

AN - SCOPUS:0042671494

VL - 307

SP - 696

EP - 703

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -